Endpoints News
Agency sign-off comes more than a week ahead of deadline Read in browser
Endpoints News
ALERT
Thank you for reading, dupa dupackia!
basic
UPGRADE
Breaking News

Now Eli Lil­ly has an obe­si­ty pill, too. On Wednes­day, the FDA ap­proved or­for­glipron, the agency an­nounced. It will be sold as Foun­dayo, and Lil­ly has pre­vi­ous­ly said it plans to sell a start­ing dose for $149 a month and high­er dos­es for $399 a month...

Read the full story
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times